We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B Turnover 20.26%
1-Year Est. Return 43.02%
 

Nuveen is the asset management arm of TIAA, a financial services group long focused on retirement savings for universities, other not-for-profit institutions and their employees. Nuveen manages all of TIAA's capital as well as money from outside investors, and began in Chicago in 1898 as John Nuveen & Company, an investment bank founded by John Nuveen Sr. to underwrite and sell municipal bonds. Its funds cover income, equity, real estate and real assets such as farmland and timberland, alongside private equity and private debt, and Nuveen and TIAA often invest their own money alongside clients. A private equity group led by Madison Dearborn Partners bought the firm in 2007, and it merged with TIAA in 2014.

This Fund
S&P 500
This Quarter Est. Return
+26%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.67%
10 Year Est. Return
+615.17%
AUM
$419B
AUM Growth
+$49.9B
Cap. Flow
-$5.75B
Cap. Flow %
-1.37%
Top 10 Hldgs %
30.74%
Holding
3,870
New
648
Increased
1,897
Reduced
998
Closed
136
Avg Time Held
5.1 years
Top 10 Avg Time Held
4.7 years
Top 20 Avg Time Held
4.1 years

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$944M
2
HONA
Honeywell Aerospace
HONA
+$593M
3
SNDK icon
Sandisk
SNDK
+$559M
4
BKNG icon
Booking.com
BKNG
+$521M
5
MU icon
Micron Technology
MU
+$516M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.07B
2
MSFT icon
Microsoft
MSFT
+$1.51B
3
NVDA icon
NVIDIA
NVDA
+$1.18B
4
AAPL icon
Apple
AAPL
+$1.04B
5
AVGO icon
Broadcom
AVGO
+$949M

Sector Composition

Rank Sector Weight
1 Technology 35.08%
2 Financials 10.73%
3 Industrials 10.3%
4 Consumer Discretionary 9.56%
5 Healthcare 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TNXP icon
2701
Tonix Pharmaceuticals
TNXP
$77M
$1.5M ﹤0.01%
117,447
+22,886
+24% +$295K
2025 Q2
4 quarters
SOC icon
2702
Sable Offshore Corp
SOC
$169M
$1.5M ﹤0.01%
486,130
+86,980
+22% +$1.11M
2024 Q2
8 quarters
IRWD icon
2703
Ironwood Pharmaceuticals
IRWD
$775M
$1.5M ﹤0.01%
355,372
+121,960
+52% +$470K
2025 Q4
2 quarters
MBLY icon
2704
Mobileye
MBLY
$4.98B
$1.49M ﹤0.01%
154,433
-13,594
-8% -$121K
2025 Q3
3 quarters
JANX icon
2705
Janux Therapeutics
JANX
$781M
$1.49M ﹤0.01%
97,120
– –
2021 Q3
19 quarters
USMV icon
2706
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
$1.49M ﹤0.01%
+15,446
New +$1.47M
2026 Q2
0 quarters
MDXG icon
2707
MiMedx Group
MDXG
$484M
$1.49M ﹤0.01%
386,411
+149,523
+63% +$546K
2021 Q2
20 quarters
AEBI icon
2708
Aebi Schmidt Holding AG
AEBI
$885M
$1.48M ﹤0.01%
118,189
-2,729
-2% -$32.2K
2025 Q3
3 quarters
GDYN icon
2709
Grid Dynamics Holdings
GDYN
$1.07B
$1.48M ﹤0.01%
260,991
+138,964
+114% +$860K
2020 Q2
24 quarters
HELE icon
2710
Helen of Troy
HELE
$873M
$1.48M ﹤0.01%
50,885
-5,647
-10% -$134K
2019 Q1
29 quarters
MCHI icon
2711
iShares MSCI China ETF
MCHI
$5.78B
$1.48M ﹤0.01%
+28,931
New +$1.62M
2026 Q2
0 quarters
ACRS icon
2712
Aclaris Therapeutics
ACRS
$673M
$1.47M ﹤0.01%
278,404
+160,384
+136% +$715K
2025 Q2
4 quarters
CADL icon
2713
Candel Therapeutics
CADL
$726M
$1.47M ﹤0.01%
142,978
+49,820
+53% +$376K
2024 Q2
8 quarters
GLIBK icon
2714
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.09B
$1.47M ﹤0.01%
68,269
+21,639
+46% +$608K
2025 Q3
3 quarters
ATLC icon
2715
Atlanticus Holdings
ATLC
$1.25B
$1.47M ﹤0.01%
14,370
+3,861
+37% +$313K
2020 Q4
22 quarters
NPK icon
2716
National Presto Industries
NPK
$1.05B
$1.47M ﹤0.01%
11,750
+893
+8% +$121K
2019 Q2
28 quarters
KRUS icon
2717
Kura Sushi USA
KRUS
$371M
$1.47M ﹤0.01%
25,506
+12,741
+100% +$697K
2020 Q2
24 quarters
FXNC icon
2718
First National Corp
FXNC
$278M
$1.47M ﹤0.01%
48,890
+30,574
+167% +$867K
2025 Q2
4 quarters
CLW icon
2719
Clearwater Paper
CLW
$213M
$1.46M ﹤0.01%
92,942
+51,513
+124% +$776K
2019 Q2
28 quarters
MG icon
2720
Mistras Group
MG
$643M
$1.46M ﹤0.01%
83,409
+19,525
+31% +$347K
2023 Q2
12 quarters
DNA icon
2721
Ginkgo Bioworks
DNA
$833M
$1.46M ﹤0.01%
146,845
-34,904
-19% -$292K
2025 Q2
4 quarters
CRMD icon
2722
CorMedix
CRMD
$426M
$1.45M ﹤0.01%
185,274
+10,038
+6% +$79.3K
2023 Q2
12 quarters
RES icon
2723
RPC Inc
RES
$1.17B
$1.45M ﹤0.01%
248,936
+53,298
+27% +$371K
2019 Q2
28 quarters
CPS icon
2724
Cooper-Standard Automotive
CPS
$332M
$1.45M ﹤0.01%
53,537
-20,806
-28% -$613K
2023 Q2
12 quarters
CWH icon
2725
Camping World
CWH
$483M
$1.45M ﹤0.01%
189,645
+65,878
+53% +$477K
2019 Q2
28 quarters

Similar funds

Nuveen's Q2 2026 Portfolio in Review

As of Q2 2026, Nuveen held 3,870 positions worth $419B, up 14% from $369B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Nuveen's Q2 2026 filing shows 648 new, 1,897 increased, 998 reduced and 136 closed positions. Its largest new stake was Honeywell Aerospace: 2,688,848 shares worth $594M. The largest sale was Amazon, an estimated $2.07B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • Nuveen's largest Q2 2026 buy was Honeywell Aerospace: 2,688,848 shares worth $594M.
  • Nuveen added most to Tesla in Q2 2026, an estimated $944M increase.
  • Nuveen's biggest Q2 2026 reduction was Amazon, cutting an estimated $2.07B.
  • Nuveen fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, selling an estimated $393M.
  • Nuveen's ten largest holdings make up 31% of its $419B portfolio in Q2 2026.
  • Nuveen opened 648 new positions and closed 136 in Q2 2026.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $419B.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.